Accolade, a company that provides personalized solutions that help people better understand, navigate, and use the healthcare system and their workplace benefits, has signed a definitive agreement to acquire Innovation Specialists, LLC (d/b/a 2nd.MD), a leading expert medical opinion and decision support company. Healthcare utilization is...
GRAIL today announced a collaboration with global biopharmaceutical companies Amgen, AstraZeneca, and Bristol Myers Squibb to evaluate GRAIL’s methylation-based technology for the detection of minimal residual disease (MRD). Cancer MRD testing is used in clinical and research applications to detect the presence or absence of residual...
GRAIL has confirmed that it expects to introduce Galleri™, its multi-cancer early detection blood test, in the second quarter of 2021. In December 2020, GRAIL completed the enrollment of PATHFINDER, a prospective, 6,600-participant multi-site interventional study conducted under a U.S. Food and Drug Administration Investigational Device...
McKesson Ventures has added Lizzie Lee as its newest team member. She joins the firm as senior director, leading its portfolio development and market research efforts. With a decade of healthcare experience, Lee is well-positioned to help McKesson Ventures’ portfolio companies scale by developing and facilitating...
Aspen RxHealth, developer of a first-of-its-kind clinical pharmacy model developed by pharmacists for pharmacists that delivers value for health plans and risk-bearing providers, today announced the closure of a $23 million Series B funding round led by Bessemer Venture Partners, with participation from other strategic...
Telehealth usage skyrocketed in the early stages of the COVID-19 pandemic. According to data from EHR vendor Epic Systems, telehealth visits peaked in mid-April, when telehealth accounted for 69 percent of all ambulatory care visits. Although the percentage dropped to 21 percent by mid-July, telehealth...
Colin Hung recently interviewed Chris Gervais, CTO and CSO at Kyruus; and Pamela Landis, vice president of digital engagement at Hackensack Meridian Health, for a discussion of healthcare access and the importance of that access in light of the COVID-19 pandemic. Gervais began by saying that...
On a recent episode of Wharton Digital Health’s The Pulse podcast, Hims & Hers Founder and CEO Andrew Dudum discussed a wide range of topics including how Hims & Hers disrupted the $4 trillion healthcare industry by creating a telehealth tool that makes Americans’ medical...
McKesson Corporation today announced the launch of Ontada, an oncology technology and insights business designed to support innovation, acceleration, and evidence generation to drive better outcomes for patients with cancer. Building on McKesson’s long history in community oncology, Ontada combines its real-world data and research capabilities...
Clinical Ink, a global clinical trial technology company, today announced an investment from McKesson Ventures, along with its significantly enhanced electronic patient reported outcome (ePRO) module. “McKesson Ventures is excited to invest in Clinical Ink, a market leader in clinical trial enablement technology,” said Dave Schulte,...